Brokers Offer Predictions for Option Care Health, Inc.’s FY2024 Earnings (NASDAQ:OPCH)

Option Care Health, Inc. (NASDAQ:OPCH) – Equities researchers at Barrington Research raised their FY2024 earnings per share estimates for shares of Option Care Health in a research report issued on Thursday, August 1st. Barrington Research analyst M. Petusky now forecasts that the company will post earnings of $1.20 per share for the year, up from their prior estimate of $1.15. Barrington Research currently has a “Outperform” rating and a $40.00 price target on the stock. The consensus estimate for Option Care Health’s current full-year earnings is $1.21 per share. Barrington Research also issued estimates for Option Care Health’s Q4 2024 earnings at $0.34 EPS, Q1 2025 earnings at $0.28 EPS, Q2 2025 earnings at $0.34 EPS, Q3 2025 earnings at $0.36 EPS, Q4 2025 earnings at $0.41 EPS, FY2025 earnings at $1.40 EPS and FY2026 earnings at $1.62 EPS.

Option Care Health (NASDAQ:OPCH) last announced its quarterly earnings data on Wednesday, July 31st. The company reported $0.30 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $0.27 by $0.03. Option Care Health had a return on equity of 14.82% and a net margin of 4.60%. The company had revenue of $1.23 billion during the quarter, compared to the consensus estimate of $1.17 billion. During the same period in the previous year, the company posted $0.63 EPS. The firm’s revenue was up 14.8% on a year-over-year basis.

Separately, JMP Securities assumed coverage on Option Care Health in a report on Tuesday, July 16th. They issued an “outperform” rating and a $36.00 price target on the stock.

Option Care Health Stock Up 0.3 %

NASDAQ OPCH opened at $29.78 on Monday. The stock’s 50 day moving average is $29.12 and its 200 day moving average is $30.63. The company has a current ratio of 1.76, a quick ratio of 1.39 and a debt-to-equity ratio of 0.78. Option Care Health has a 12 month low of $26.11 and a 12 month high of $35.74. The stock has a market cap of $5.18 billion, a PE ratio of 19.59, a P/E/G ratio of 2.33 and a beta of 1.24.

Institutional Trading of Option Care Health

Hedge funds have recently modified their holdings of the company. Mutual of America Capital Management LLC raised its holdings in shares of Option Care Health by 63.3% during the 4th quarter. Mutual of America Capital Management LLC now owns 190,684 shares of the company’s stock worth $6,424,000 after acquiring an additional 73,938 shares in the last quarter. Westfield Capital Management Co. LP raised its holdings in shares of Option Care Health by 19.6% during the 4th quarter. Westfield Capital Management Co. LP now owns 4,482,732 shares of the company’s stock worth $151,023,000 after acquiring an additional 735,344 shares in the last quarter. Principal Financial Group Inc. raised its holdings in shares of Option Care Health by 6.9% during the 4th quarter. Principal Financial Group Inc. now owns 968,233 shares of the company’s stock worth $32,620,000 after acquiring an additional 62,449 shares in the last quarter. HealthInvest Partners AB purchased a new stake in Option Care Health during the 4th quarter valued at $1,254,000. Finally, Schroder Investment Management Group raised its holdings in Option Care Health by 7.3% during the 4th quarter. Schroder Investment Management Group now owns 1,417,591 shares of the company’s stock valued at $47,759,000 after buying an additional 96,587 shares during the period. 98.05% of the stock is owned by hedge funds and other institutional investors.

About Option Care Health

Option Care Health, Inc offers home and alternate site infusion services in the United States. The company provides anti-infective therapies; home infusion services to treat heart failures; home parenteral nutrition and enteral nutrition support services for numerous acute and chronic conditions, such as stroke, cancer, and gastrointestinal diseases; immunoglobulin infusion therapies for the treatment of immune deficiencies; and treatments for chronic inflammatory disorders, including crohn's disease, plaque psoriasis, psoriatic arthritis, rheumatoid arthritis, ulcerative colitis, and other chronic inflammatory disorders.